Cambrian Bio

Drug Discovery · New York, NY · Founded 2019 · Privately Held (backing)

Developer of a portfolio of medicines designed to target the causes of age-related diseases. Cambrian Bio is based in New York, NY and was founded in 2019. Its last reported valuation was $180 million in Aug 2023. It has raised $204 million across 1 recorded round; the latest was a $23.8 million later-stage round in Dec 2025.

Last reported valuation
$180.0M
Oct 2026
Priced at
—
Total raised
$204.1M
Last round
Later Stage VC
Dec 2025
How much has Cambrian Bio raised?
$204.1Macross 1 recorded rounds · Dec 2025 – Dec 2025

Most recently, Cambrian Bio raised $23.8M in its Later Stage VC (Dec 2025).

Free account
More of Cambrian Bio with a free account
  • ·The complete investor list: 41 names
  • ·Watch Cambrian Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Cambrian Bio round by round

1 rounds
Dec 2025Later Stage VC$23.8M▮
+ 1 more investors · free account

How much has Cambrian Bio raised?

Cambrian Bio has raised $204 million in total; 1 of its rounds is on record. The largest on record was a $23.8 million later-stage round in Dec 2025.

Cambrian Bio investors

41 investors are on record for Cambrian Bio, including Alumni Ventures, FJ Labs, Gaingels and RA Capital Management. By type, the record holds 15 venture capital firms, 3 family offices and 2 hedge funds. The later-stage round in Dec 2025 drew 11 investors.

For fundraisers
Raising for a company like Cambrian Bio?

41 investors have backed Cambrian Bio — start your target list with the firms already writing checks in drug discovery.

See all 41 investors →

Frequently asked about Cambrian Bio

How much has Cambrian Bio raised?
Cambrian Bio has raised $204.1M in total across 1 recorded funding rounds.
When was Cambrian Bio's last funding round?
Cambrian Bio's most recent recorded round was Later Stage VC in Dec 2025, raising $23.8M.